CA2568823C — Vaginally administrable progesterone-containing tablets and method for preparing same
Assigned to Ferring BV · Expires 2012-02-07 · 14y expired
What this patent protects
The present invention discloses a method for preparing a tablet for the vaginal administration of progesterone for systemic use. Tablets prepared by this method are also disclosed. Also disclosed are methods for vaginally administering such tablets three times a day to female pat…
USPTO Abstract
The present invention discloses a method for preparing a tablet for the vaginal administration of progesterone for systemic use. Tablets prepared by this method are also disclosed. Also disclosed are methods for vaginally administering such tablets three times a day to female patients being treated for infertility or other pregnancy-related conditions and disorders in an IVF program. In addition, disclosed are methods of administering a tablet containing 100 mg of natural progesterone at least three times per day to female patients who require stronger luteal support, e.g., older patients and overweight or obese patients, and patients in a donor oocyte program.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.